Schedule 13G ownership disclosure

Paratek Pharmaceuticals Inc

Security class unavailable · CUSIP: 699374302

Event date: 2017-03-10

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,203,202
Percent of class
4.9500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-17-018619
Form type
SC 13G/A
Filer
HBM Healthcare Investments (Cayman) Ltd.
CIK
CIK 1232258
Filed
Mar 22, 2017
Reporting period
Mar 10, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub